Patricia Carr Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

Patricia Carr is SVP, Chief Accounting Officer of Jazz Pharmaceuticals plc. Currently has a direct ownership of 9,485 shares of JAZZ, which is worth approximately $1.32 Million. The most recent transaction as insider was on Feb 28, 2025, when has been sold 773 shares (Ordinary Shares) at a price of $143.29 per share, resulting in proceeds of $110,763. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.49K

43.8% 3M change

43.8% 12M change

Total Value Held $1.32 Million

Patricia Carr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2025	SELL Open market or private sale	$110,763 $143.29 p/Share	773 Reduced 7.54%	9,485 Ordinary Shares
Feb 27 2025	SELL Sale (or disposition) back to the issuer	$123,629 $142.43 p/Share	868 Reduced 10.54%	7,369 Ordinary Shares
Feb 27 2025	SELL Open market or private sale	$695,093 $144.42 p/Share	4,813 Reduced 36.88%	8,237 Ordinary Shares
Feb 27 2025	BUY Exercise of conversion of derivative security	$569,040 $118.23 p/Share	4,813 Added 36.02%	8,550 Ordinary Shares
Feb 27 2025	BUY Grant, award, or other acquisition	-	2,889 Added 21.97%	10,258 Ordinary Shares
Jan 17 2025	BUY Grant, award, or other acquisition	-	1,641 Added 16.61%	8,237 Ordinary Shares
Dec 02 2024	SELL Open market or private sale	$6,491 $122.49 p/Share	53 Reduced 0.8%	6,596 Ordinary Shares
Jun 07 2024	SELL Open market or private sale	$17,739 $108.83 p/Share	163 Reduced 2.41%	6,596 Ordinary Shares
Mar 07 2024	SELL Open market or private sale	$206,820 $116.98 p/Share	1,768 Reduced 21.14%	6,596 Ordinary Shares
Mar 06 2024	SELL Open market or private sale	$230,732 $119.18 p/Share	1,936 Reduced 18.8%	8,364 Ordinary Shares
Mar 01 2024	BUY Grant, award, or other acquisition	-	2,987 Added 22.48%	10,300 Ordinary Shares
Jan 17 2024	BUY Grant, award, or other acquisition	-	1,327 Added 15.27%	7,363 Ordinary Shares
Aug 29 2023	SELL Open market or private sale	$20,372 $143.47 p/Share	142 Reduced 2.32%	5,986 Ordinary Shares
Aug 14 2023	SELL Open market or private sale	$21,829 $138.16 p/Share	158 Reduced 2.51%	6,128 Ordinary Shares
Jun 07 2023	SELL Open market or private sale	$16,117 $127.92 p/Share	126 Reduced 1.97%	6,286 Ordinary Shares
Mar 15 2023	SELL Open market or private sale	$136,284 $133.22 p/Share	1,023 Reduced 14.0%	6,286 Ordinary Shares
Mar 05 2023	SELL Open market or private sale	$161,592 $140.76 p/Share	1,148 Reduced 13.57%	7,309 Ordinary Shares
Mar 03 2023	BUY Grant, award, or other acquisition	-	2,523 Added 22.98%	8,457 Ordinary Shares
Dec 05 2022	SELL Open market or private sale	$9,579 $152.06 p/Share	63 Reduced 1.05%	5,934 Ordinary Shares
Aug 15 2022	SELL Open market or private sale	$339,657 $158.57 p/Share	2,142 Reduced 26.52%	5,934 Ordinary Shares
Aug 15 2022	BUY Exercise of conversion of derivative security	$226,200 $113.1 p/Share	2,000 Added 20.13%	7,934 Ordinary Shares
Aug 08 2022	SELL Open market or private sale	$24,068 $152.33 p/Share	158 Reduced 2.53%	6,076 Ordinary Shares
Jun 02 2022	SELL Open market or private sale	$19,684 $150.26 p/Share	131 Reduced 2.06%	6,234 Ordinary Shares
May 11 2022	SELL Open market or private sale	$106,502 $147.51 p/Share	722 Reduced 10.38%	6,234 Ordinary Shares
May 10 2022	SELL Open market or private sale	$39,361 $144.18 p/Share	273 Reduced 3.78%	6,956 Ordinary Shares

Patricia Carr

SVP, Chief Accounting Officer

Dublin 4, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Value

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ

Account